 |
 |
 |
Gilles BosCEO |
Silvia SchererManaging Director Aesthetics |
Olivier BenoitManaging Director Healthcare |
 |
 |
 |
Sylvain DucretCFO |
Cyrille VinchonR&D Director |
Denis RigoletOperations Senior Director |
recommendprint this page top
Ophteis range
Ophteisbio range
Methylvisc range
Healaflow
Esthélis range
Fortélis range
Modélis range
Mesolis range
Anteis Injection System
To reach an Anteis representative by telephone or email, select the appropriate link below.
" 50 % of the pain relief is gained since the first intra-articular injection " - SYNOLIS V-A is an innovative, new generation treatment for symptomatic osteoarthritis.
Our glossary gives you a better understanding of certain technical terms. Just click on the highlighted words or follow this link ...